78 results
8-K
EX-99.2
AXDX
Accelerate Diagnostics Inc
6 Nov 20
Accelerate Diagnostics Reports Third Quarter 2020 Financial Results
4:19pm
CPT final determination coverage from CMS for our Pheno ID/AST blood test. The reimbursement is above our list price and will cover the cost for our … customers when treating patients in the outpatient setting. Equally important, the newly established reimbursement provides independent validation
8-K
EX-10.1
AXDX
Accelerate Diagnostics Inc
8 Aug 19
Accelerate Diagnostics Reports Second Quarter 2019 Financial Results
4:08pm
policy. The form of Nonqualified Stock Option Agreement to be used for the Option is attached hereto asExhibit C.
Reimbursement for
Relocation Expenses … :
We will reimburse you up to $200,000 of expenses incurred in connection with your relocation to the Tucson metropolitan area. To obtain reimbursement
10QSB
2003 Q2
EX-10.1
AXDX
Accelerate Diagnostics Inc
14 Mar 03
Quarterly report (small business)
12:00am
to terminate this Agreement at the end of the Initial Term or any such
Renewal Term.
3. Compensation; Reimbursement.
3.1 Base Salary. For all … Life Insurance, Executive shall be
entitled to all other benefits of employment provided to the employees of the
Company.
3.6 Reimbursement
8-K
EX-99.2
AXDX
Accelerate Diagnostics Inc
15 Jan 20
Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2019
6:03am
reimbursement decision expected 2H 2020 2. CPT reimbursement for outpatient in process 3. Expected Rapid ID/AST in 2021 CLSI guidelinesOUTCOMES DATA
10QSB
2008 Q1
EX-10.2
AXDX
Accelerate Diagnostics Inc
17 Dec 07
Quarterly report (small business)
12:00am
this
Agreement at the end of the Initial Term or any such Renewal Term.
3. Compensation; Reimbursement.
3.1 Base Salary. For all services … Life Insurance,
Executive shall be entitled to all other benefits of employment provided to the
employees of the Company.
3.8 Reimbursement
8-K
EX-99.2
eiix8
14 May 18
Accelerate Diagnostics reports Q1 2018 financial results
5:29pm
424B1
7vqv3qko4qa
22 Jan 24
Prospectus with pricing info
9:59pm
S-1
j2xtkzd8in2m ef9
13 Dec 23
IPO registration
5:30pm
S-1/A
1t3g2mkfj12gm4n
16 Jan 24
IPO registration (amended)
7:18am